Issue 8/2014
Content (10 Articles)
Bridging Islands of Information to Establish an Integrated Knowledge Base of Drugs and Health Outcomes of Interest
Richard D. Boyce, Patrick B. Ryan, G. Niklas Norén, Martijn J. Schuemie, Christian Reich, Jon Duke, Nicholas P. Tatonetti, Gianluca Trifirò, Rave Harpaz, J. Marc Overhage, Abraham G. Hartzema, Mark Khayter, Erica A. Voss, Christophe G. Lambert, Vojtech Huser, Michel Dumontier
Advancing the Field of Pharmaceutical Risk Minimization Through Application of Implementation Science Best Practices
Meredith Y. Smith, Elaine Morrato
A Comparison of Active Adverse Event Surveillance Systems Worldwide
Yu-Lin Huang, Jinhee Moon, Jodi B. Segal
Benefit-Risk Assessment of Orlistat in the Treatment of Obesity
Priya Sumithran, Joseph Proietto
Identification of Suicide-Related Events Through Network Analysis of Adverse Event Reports
Alwis Nazir, Takashi Ichinomiya, Nobuteru Miyamura, Yasuaki Sekiya, Yasutomi Kinosada
Improved Statistical Signal Detection in Pharmacovigilance by Combining Multiple Strength-of-Evidence Aspects in vigiRank
Ola Caster, Kristina Juhlin, Sarah Watson, G. Niklas Norén
Undesirable Effects Related to Oral Antineoplastic Drugs: Comparison Between Patients’ Internet Narratives and a National Pharmacovigilance Database
Arnaud Pages, Emmanuelle Bondon-Guitton, Jean Louis Montastruc, Haleh Bagheri
Indicators of Drug-Seeking Aberrant Behaviours: The Feasibility of Use in Observational Post-Marketing Cohort Studies for Risk Management
Deborah Layton, Vicki Osborne, Mohammad Al-Shukri, Saad A. W. Shakir
Erratum to: Association of Statin Use with Sleep Disturbances: Data Mining of a Spontaneous Reporting Database and a Prescription Database
Mitsutaka Takada, Mai Fujimoto, Kohei Yamazaki, Masashi Takamoto, Kouichi Hosomi